1 / 28

Percent of patients 66.3+ (71.3) 60.2 to <66.3 55.2 to <60.2 47.2 to <55.2 below 47.2 (37.6)

Percent of patients receiving influenza vaccinations figure 5.1, hemodialysis patients, by HSA, unadjusted. Percent of patients 66.3+ (71.3) 60.2 to <66.3 55.2 to <60.2 47.2 to <55.2 below 47.2 (37.6).

elliote
Download Presentation

Percent of patients 66.3+ (71.3) 60.2 to <66.3 55.2 to <60.2 47.2 to <55.2 below 47.2 (37.6)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Percent of patients receivinginfluenza vaccinationsfigure 5.1, hemodialysis patients, by HSA, unadjusted Percent of patients 66.3+ (71.3) 60.2 to <66.3 55.2 to <60.2 47.2 to <55.2 below 47.2 (37.6)

  2. Percent of patients hospitalizedfigure 5.2, hemodialysis patients, by HSA, Q4 1999 pts, admitted Q1 2000, unadjusted Percent of patients 30.2+ (31.5) 29.2 to <30.2 28.2 to <29.2 26.8 to <28.2 below 26.8 (25.4))

  3. Percent of patients dyingfigure 5.3, hemodialysis patients, by HSA, Q4 1999 pt cohort, died in Q1 2000, unadjusted Percent of patients 6.77+ (6.98) 6.60 to <6.77 6.41 to <6.60 6.13 to <6.41 below 6.13 (5.89)

  4. Pre- & post-ESRD patients (age 67+) care for influenza vaccinations figure 5.4, by age, & race/ethnicity, fall of pre-ESRD to fall of post-ESRD

  5. Pre- & post-ESRD patients (age 67+) care for pneumonia vaccinations figure 5.5, by age, & race/ethnicity

  6. Vaccination rates in the two years pre-ESRD & two years post-ESRDfigure 5.6, ESRD patients 67+, by HSA, unadjusted Percent of patients 34.9 (37.7) 31.4 to <34.9 29.0 to <31.4 26.5 to <29.0 below 26.5 (23.5)

  7. Pre- & post-ESRD patients diabetic care: receiving diabetic eye exams figure 5.7, patients 67+, by race/ethnicity

  8. Pre- & post-ESRD patients diabetic care: receiving lipid testing figure 5.8, patients 67+, by race/ethnicity

  9. Pre- & post-ESRD patients diabetic care: receiving glycosylated hemoglobin testing figure 5.9, patients 67+, by race/ethnicity

  10. Diabetic eye exams in ESRD & non-ESRD patients: ESRD patientsfigure 5.10, patients age 65–75, by HSA, unadjusted Percent of patients 60.0+ (62.8) 59.4 to <60.0 59.0 to <59.4 58.5 to <59.0 below 58.5 (57.7)

  11. Diabetic eye exams in ESRD & non-ESRD patients: general Medicare patientsfigure 5.10, patients age 65–75, by HSA, unadjusted Percent of patients 60.0+ (64.8) 59.4 to <60.0 59.0 to <59.4 58.5 to <59.0 below 58.5 (54.8)

  12. Diabetic eye exams in ESRD patientsfigure 5.11, patients age 18–75, by age, race/ethnicity, & modality

  13. Lipid monitoring in diabetic patients:ESRD patientsfigure 5.12, patients age 65–75, by HSA, unadjusted Percent of patients 65.1+ (72.0) 60.4 to <65.1 56.4 to <60.4 42.9 to <56.4 below 42.9 (35.9)

  14. Lipid monitoring in diabetic patients:general Medicare patientsfigure 5.12, patients age 65–75, by HSA, unadjusted Percent of patients 65.1+ (68.9) 60.4 to <65.1 56.4 to <60.4 42.9 to <56.4 below 42.9 (NA)

  15. Lipid monitoring in diabetic patientsfigure 5.13, patients age 18–75, by age, race/ethnicity, & modality

  16. Glycosylated hemoglobin (HbA1c) testing in diabetic patients: ESRD patientsfigure 5.14, patients age 65–75, by HSA, unadjusted Percent of patients 78.4+ (81.1) 75.1 to <78.4 72.2 to <75.1 61.5 to <72.2 below 61.5 (51.5)

  17. Glycosylated hemoglobin (HbA1c) testing in diabetic patients: general Medicare patientsfigure 5.14, patients age 65–75, by HSA, unadjusted Percent of patients 78.4+ (80.5) 75.1 to <78.4 72.2 to <75.1 61.5 to <72.2 below 61.5 (60.7)

  18. Glycosylated hemoglobin (HbA1c) monitoring in diabetic patientsfigure 5.15, patients age 18–75, by age, race/ethnicity, & modality

  19. Frequency of Glycosylated hemoglobin (HbA1c) testing in ESRD & general Medicare patientsfigure 5.16, patients age 65–75, by the number of tests in pts surviving 1 year

  20. Patients receiving breast cancer screeningfigure 5.17, female ESRD patients age 52–69, by HSA, unadjusted Percent of patients 42.5+ (43.9) 41.8 to <42.5 41.0 to <41.8 39.9 to <41.0 below 39.9 (38.6)

  21. Patients receiving cervical cancer screeningfigure 5.18, female ESRD patients age 21–64, by HSA, unadjusted Percent of patients 41.2+ (43.1) 39.3 to <41.2 37.6 to <39.3 36.7 to <37.6 below 36.7 (35.5)

  22. Patients receiving prostate cancer screeningfigure 5.19, male ESRD patients age 50+, by HSA, unadjusted Percent of patients 36.4+ (43.0) 32.7 to <36.4 29.9 to <32.7 26.6 to <29.9 below 26.6 (23.6)

  23. Breast cancer screeningfigure 5.20, female ESRD patients age 52–69, by age, race/ethnicity, & modality

  24. Breast cancer screening in ESRD & general Medicare patientsfigure 5.21, female patients age 52–69, by age, race/ethnicity, & patient pop.

  25. Cervical cancer screeningfigure 5.22, female ESRD patients age 21–64, by age, race/ethnicity, & modality

  26. Cervical cancer screening in ESRD & general Medicare patientsfigure 5.23, female patients age 52–69, by age, race/ethnicity, & patient pop.

  27. Prostate cancer screeningfigure 5.24, male ESRD patients age 50+, by age, race/ethnicity, & modality

  28. Prostate cancer screening in ESRD & general Medicare patientsfigure 5.25, male patients age 50+, by age, race/ethnicity, & patient pop.

More Related